Metabolism of retinoic acid: Implications for development and cancer

International Journal for Vitamin and Nutrition Research

Volumn 68, Issue 6, 1998, Pages 404-410

  Sonneveld, Edwin ^a   Van Der Saag, Paul T ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

Author keywords

Cancer; CYP26; Cytochrome P450; Development; Metabolism; Retinoic acid receptors; Retinoids

Indexed keywords

RETINOIC ACID; RETINOID BINDING PROTEIN;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; NEOPLASMS; RECEPTORS, RETINOIC ACID; TRETINOIN;

DANIO RERIO;

EID: 0031794371     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. De Luca, L.M., Darwiche, N., Celli, G., Kosa, K., Jones, C., Ross, S. and Chen, L.C. (1994) Vitamin A in epithelial differentiation and skin carcinogenesis. Nutr. Rev. 52, 45-52.
2. Mangelsdorf, D.J., Umesono, K. and Evans, R.M. (1994) The retinoid receptors. In: The retinoids: biology, chemistry, and medicine, 2nd ed. (Sporn, M.B., Roberts, A.B. and Goodman, D.S., eds.), pp. 319-349, Raven Press, New York.
3. Leid, M., Kastner, P. and Chambon, P. (1992) Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17, 427-433.
4. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J.-Y., Staub, A., Garnier, J.-M., Mader, S. and Chambon, P. (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377-395.
5. De Thé, H., del Mar Vivanco-Ruiz, M., Tiollais, P., Stunnenberg, H. and Dejean, A. (1990) Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343, 177-180.
6. Gudas, L.J. (1992) Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Diff. 3, 655-662.
7. Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M. and Thaller, C. (1992) 9-cis-retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397-406.
8. Pijnappel, W.W.M., Hendriks, H.F.J., Folkers, G.E., van den Brink, C.E., Dekker, E.J., Edelenbosch, C., van der Saag, P.T. and Durston, A.J. (1993) The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 366, 340-344.
9. Wouters, W., van Dun, J., Dillen, A., Coene, M.-C., Cools, W. and de Coster, R. (1992) Effects of liarozole, a new antitumor compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res. 52, 2841-2846.
10. Nebert, D.W. (1991) Proposed role of drug-metabolizing enzymes: regulation of steady-state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine function. Mol. Endocrinol. 5, 1203-1214.
11. Nedelcheva, V. and Gut, I. (1994) P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotica 24, 1151-1175.
12. Nelson, D.R., Koymans, L., Kamataki, T., Stegeman, J.J., Feyereisen, R., Waxman, D.J., Waterman, M.R., Gotoh, O., Coon, M.J., Estabrook, R.W., Gunsalus, I.C. and Nebert, D.W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
13. Guengerich, F.P. (1992) Human cytochrome-P450 enzymes. Life Sci. 50, 1471-1478.
14. Roberts, A.B., Nichols, M.D., Newton, D.L. and Sporn, M.B. (1979) In vitro metabolism of retinoic acid in hamster intestine and liver. J. Biol. Chem. 254, 6296-6302.
15. Eckhoff, C., Collins, M.D. and Nau, H. (1991) Human plasma all-trans-, 13-cis and 13-cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels. J. Nutr. 121, 1016-1025.
16. 3H]retinoic acid after an oral dose in rats. Biochem. J. 277, 527-531.
17. Van Wauwe, J.P., Coene, M.C., Goosens, J., Van Nijen, G., Cools, W. and Lauwers, W. (1988) Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J. Pharmacol. Exp. Ther. 245, 718-722.
18. Bruynseels, J.R., de Coster, R., van Rooy, P., Wouters, W., Coene, M.C., Snoeck, E., Raeymaekers, A., Freyne, E., Sanz, G., van den Bussche, G., van den Bossche, H., Willemsens, G. and Janssen, P.A.J. (1990) R-75251, a new inhibitor of steroid biosynthesis. Prostate 16, 345-357.
19. Leo, M.A. and Lieber, C.S. (1985) New pathway for retinol metabolism in liver microsomes. J. Biol. Chem. 260, 5228-5231.
20. Roberts, E.S., Vaz, A.D.N. and Coon, M.J. (1992) Role of isoenzymes of rabbit microsomal cytochrome P450 in the metabolism of retinoic acid, retinol and retinal. Mol. Pharmacol. 41, 427-433.
21. Leo, M.A., Kim, N., Lowe, N. and Lieber, C.S. (1989) Increased hepatic retinal dehydrogenase activity after phenobarbital and ethanol administration. Biochem. Pharmacol. 38, 97-103.
22. Westin, S., Sonneveld, E., van der Leede, B.M., van der Saag, P.T., Gustafsson, J.A. and Mode, A. (1997) CYP2C7 expression in rat liver and hepatocytes: regulation by retinoids. Mol. Cell. Endocrinol. 129, 169-179.
23. Vecchini, F., Lenoir-Viale, M.C., Cathelineau, C., Magdalou, J., Bernard, B.A. and Shroot, B. (1994) Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem. Biophys. Res. Commun. 201, 1205-1212.
24. Takatsuka, J., Takahashi, N. and De Luca, L.M. (1996) Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res. 56, 675-678.
25. Van der Leede, B.M., van den Brink, C.E., Pijnappel, W.W.M., Sonneveld, E., van der Saag, P.T. and van der Burg, B. (1997) Auto-induction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells. J. Biol. Chem. 272, 17921-17928.
26. Sonneveld, E., van den Brink, C.E., van der Leede, B.M., Schulkes, R.A.M., Petkovich, M. and van der Saag, P.T. (1998) Human retinoic acid 4-hydroxylase (CYP26) is highly specific for all-trans RA, and can be induced through retinoic acid receptors in human breast and colon carcinoma cells. Cell Growth Differ., in press.
27. White, J.A., Guo, Y.D., Baetz, K., Beckett-Jones, B., Bonasoro, J., Hsu, K.E., Dilworth, F.J., Jones, G. and Petkovich, M. (1997) Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 277, 29922-29927.
28. Fujii, H., Sato, T., Kaneko, S., Gotoh, O., Fujii-Kuriyama, Y., Osawa, K., Kato, S. and Hamada, H. (1997) Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J. 16, 4163-4173.
29. Ray, W.J., Bain, G., Yao, M. and Gottlieb, D.I. (1997) CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J. Biol. Chem. 272, 18702-18708.
30. White, J.A., Beckett-Jones, B., Guo, Y.D., Dilworth, F.J., Bonasoro, J., Jones, G. and Petkovich, M. (1997) cDNA cloning of human retinoic acid metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450 (CYP26). J. Biol. Chem. 272, 18538-18541.
31. Abu-Abed, S.S., Beckett, B.R., Chiba, H., Chithalen, J.V., Jones, G., Metzger, D., Chambon, P. and Petkovich, M. (1998) Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor γ and retinoid X receptor α. J. Biol. Chem. 273, 2409-2415.
32. Boylan, J.F., Lufkin, T., Achkar, C.C., Taneya, R., Chambon, P. and Gudas, L.J. (1995) Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol. 15, 843-851.
33. 3 to calcitroic acid: evidence for a pathway in kidney and bone involving 24-oxidation. Biochem. J. 262, 173-180.
34. 3 24-hydroxylase gene. J. Biol. Chem. 271, 30381-30385.
35. Joore, J., van der Lans, G.B.L.J., Lanser, P.H., Vervaart, J.M.A., Zivkovic, D., Speksnijder, J.E. and Kruijer, W. (1994) Effects of retinoic acid on the expression of retinoic acid receptors during zebrafish embryogenesis. Mech. Develop. 46, 137-150.
36. Durston, A.J., Timmermans, J.P., Hage, W.J., Hendriks, H.F., de Vries, N.J., Heideveld, M. and Nieuwkoop, P.D. (1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 340, 140-144.
37. Amos, B. and Lotan, R. (1990) Retinoid-sensitive cells and cell lines. Meth. Enzymol. 190, 217-225.
38. Moon, R.C., Mehta, R.G. and Rao, K.V.N. (1994) Retinoids and cancer in experimental animals. In: The retinoids: biology, chemistry, and medicine, 2nd ed. (Sporn, M.B., Roberts, A.B. and Goodman, D.S., eds.), pp. 573-595, Raven Press, New York.
39. Hong, W.K. and Itri, L.M. (1994) Retinoids and human cancer. In: The retinoids: biology, chemistry, and medicine, 2nd ed. (Sporn, M.B., Roberts, A.B. and Goodman, D.S., eds.), pp. 597-630, Raven Press, New York.
40. Verma, A.K. (1991) Modulation of carcinogenesis by vitamin A and its analogs (retinoids). In: Contemporary issues in clinical nutrition (Laidlaw, S.A. and Swendseid, M.E., ed.). vol 14, pp. 25-37, Wiley-Liss, New York.
41. Muindi, J., Frankel S.R., Miller, W.H., Jakubowski, A., Scheinberg, D.A., Young, C.W., Dmitrovsky, E. and Warrell, R.P. (1992) Continuous treatment with all-trans retinoic acid results in a progressive decrease in plasma concentrations: implications for relapse and "resistance" in acute promyelocytic leukemia. Blood 79, 299-303.
42. Rigas, J.R., Francis, P.A., Muindi, J.R.F., Kris, M.G., Huselton, C., DeGrazia, E. Orazem, J.P., Young, C.W. and Warrell, J.P. (1993) Constitutive variability in the pharmacokinetics of the natural retinoid all-trans-retinoic acid and its modulation by ketoconazole. J. Natl. Cancer Inst. 85, 1921-1922.
43. Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., Miyawaki, S., Ueda, R., Naoe, T. and Ohno, R. (1997) Treatment with a new synthetic retinoid, am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 90, 967-973.
44. Fregne, E., Raeymakers, A., Venet, M., Sanz, G., Wouters, W., Decoster, R. and Vanwauwe, J. (1998) Synthesis of liazal (tm), a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology. Bioorg. Med. Chem. Lett. 8, 267-272.
45. White, J.A., Beckett, B., Scherer, S.W., Herbrick, J. and Petkovich, M. (1998) P450RAI (CYP26A1) maps to human chromosome 10q23-q24 and mouse chromosome 19C2-3. Genomics 48, 270-272.
46. Gray, I.C., Phillips, S.M., Lee, S.J., Neoptolemos, J.P., Weissenbach, J. and Spurr, N.K. (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55, 4800-4803.
47. Gurrieri, E. Prinos, P., Tackels, D., Kilpatrick, M.W., Allanson, J., Genuardi, M., Vuckov, A., Nanni, L., Sangiorgi, E., Garofalo, G., Nunes, M.E., Neri, G., Schwartz, C. and Tsipouras, P. (1996) A split hand-split foot (SHFM3) gene is located at 10q24-25. Am. J. Med. Genet. 62, 427-436.